lagerhans islet peptide, pharmaceutical composition, method for stimulating islet neogenesis or stimulating langerhans islet regeneration and method for treating a condition associated with defective pancreatic function in an individual

摘要

Embodiments relate to proislet peptides, preferably HIP, that exhibit increased stability and efficacy, and methods of using the same to treating a pathology associated with impaired pancreatic function, including type 1 and type 2 diabetes and symptoms thereof.